Pharma Mar (PHMMF) Short Interest Ratio & Short Volume $88.18 0.00 (0.00%) As of 05/1/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Pharma Mar Short Interest DataPharma Mar (PHMMF) has a short interest of 39,600 shares, representing 0.22% of the float (the number of shares available for trading by the public). This marks a 21.10% increase in short interest from the previous month. The short interest ratio (days to cover) is 396.0, indicating that it would take 396.0 days of the average trading volume of 1,297 shares to cover all short positions.Current Short Interest39,600 sharesPrevious Short Interest32,700 sharesChange Vs. Previous Month+21.10%Dollar Volume Sold Short$3.49 millionShort Interest Ratio396.0 Days to CoverLast Record DateApril 15, 2025Outstanding Shares18,010,000 sharesShort Percent of Float0.22%Today's Trading Volume2 sharesAverage Trading Volume1,297 sharesToday's Volume Vs. Average0% Short Selling Pharma Mar? Sign up to receive the latest short interest report for Pharma Mar and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPHMMF Short Interest Over TimePHMMF Days to Cover Over TimePHMMF Percentage of Float Shorted Over Time Pharma Mar Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202539,600 shares $3.49 million +21.1%0.2%396 $88.18 3/31/202532,700 shares $2.88 million +0.6%0.2%16.4 $88.18 3/15/202532,500 shares $3.32 million -0.6%0.2%15.5 $102.08 2/28/202532,700 shares $3.13 million +43.4%0.2%327 $95.79 2/15/202522,800 shares $2.18 million No Change0.1%228 $95.79 1/31/202522,800 shares $2.18 million -81.4%N/A4 $95.79 1/15/2025122,400 shares $9.92 million +436.8%N/A20.7 $81.07 12/31/202422,800 shares $1.85 million No ChangeN/A3.1 $81.07 12/15/202422,800 shares $1.85 million -0.9%N/A6.2 $81.07 11/30/202423,000 shares $1.73 million -13.2%N/A230 $75.00 Get the Latest News and Ratings for PHMMF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharma Mar and its competitors with MarketBeat's FREE daily newsletter. 11/15/202426,500 shares $1.99 million -0.4%N/A265 $75.00 10/31/202426,600 shares $2.00 million +116.3%N/A266 $75.00 10/15/202412,300 shares $875,760.00 -30.9%N/A123 $71.20 9/30/202417,800 shares $961,200.00 -47.8%N/A178 $54.00 9/15/202434,100 shares $1.56 million No ChangeN/A56.8 $45.85 8/31/202434,100 shares $1.53 million -0.3%N/A341 $44.90 8/15/202434,200 shares $1.17 million -14.3%N/A342 $34.26 7/31/202439,900 shares $1.37 million -16.2%N/A399 $34.26 7/15/202447,600 shares $1.63 million -7.8%N/A476 $34.26 6/30/202451,600 shares $1.82 million -9.0%N/A516 $35.23 6/15/202456,700 shares $1.77 million -11.7%N/A566.7 $31.15 5/31/202464,200 shares $2.00 million -3.2%N/A642 $31.15 5/15/202466,300 shares $2.07 million -6.2%N/A165.8 $31.15 4/30/202470,700 shares $1.90 million -1.0%N/A707 $26.85 4/15/202471,400 shares $1.92 million -0.3%N/A714 $26.85 3/31/202471,600 shares $2.10 million +3.8%N/A716 $29.29 3/15/202469,000 shares $2.10 million +4.6%N/A345 $30.38 2/29/202466,000 shares $2.30 million -3.7%N/A110 $34.90 2/15/202468,500 shares $3.02 million No ChangeN/A685 $44.13 1/15/202490,600 shares $3.92 million +38.7%N/A906 $43.28 12/31/202365,300 shares $3.02 million -2.3%N/A1087.6 $46.26 12/15/202366,800 shares $3.09 million +0.8%N/A133.6 $46.26 11/30/202366,300 shares $2.37 million No ChangeN/A663 $35.81 11/15/202366,300 shares $2.37 million -0.2%N/A165.8 $35.81 10/31/202366,400 shares $2.13 million +0.2%N/A664 $32.10 10/15/202366,300 shares $2.13 million No ChangeN/A663 $32.10 9/30/202366,300 shares $2.21 million No ChangeN/A663 $33.34 9/15/202366,300 shares $2.29 million -0.2%N/A663 $34.47 8/31/202366,400 shares $2.56 million -48.4%N/A587.2 $38.51 8/15/2023128,600 shares $4.59 million +0.9%N/A643 $35.70Secret financial plot unfolding in Washington DC… [DEVELOPING] (Ad)What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. You see, I’ve recently uncovered a secret financial plot unfolding in Washington DC…So please take a moment to watch it now. 7/31/2023127,400 shares $4.51 million No ChangeN/A424.7 $35.43 7/15/2023127,400 shares $4.71 million -2.0%N/A212.3 $36.97 6/30/2023130,000 shares $4.68 million -0.1%N/A1300 $36.03 6/15/2023130,100 shares $4.94 million +0.9%N/A650.5 $37.96 5/31/2023128,900 shares $4.40 million -2.4%N/A1289 $34.12 5/15/2023132,100 shares $5.44 million +4.1%N/A1321 $41.21 4/30/2023126,900 shares $5.69 million No ChangeN/A1269 $44.87 4/15/2023126,900 shares $5.76 million -0.1%N/A634.5 $45.39 3/31/2023127,000 shares $6.06 million No ChangeN/A1270 $47.70 3/15/2023127,000 shares $8.81 million +33.0%N/A1270 $69.40 2/28/202395,500 shares $6.63 million +140.6%N/A955 $69.40 2/15/202339,700 shares $2.76 million -36.6%N/A397 $69.40 1/31/202362,600 shares $4.29 million +6.8%N/A626 $68.50 1/15/202358,600 shares $4.01 million -10.5%N/A586 $68.50 12/30/202265,500 shares $4.54 million -10.8%N/A655 $69.39 12/15/202273,400 shares $5.09 million -10.2%N/A367 $69.39 11/30/202281,700 shares $5.73 million -0.4%N/A26.4 $70.17 11/15/202282,000 shares $5.47 million +0.4%N/A820 $66.68 10/31/202281,700 shares $4.46 million +55.9%N/A817 $54.60 10/15/202252,400 shares $2.99 million -5.1%N/A524 $57.00 9/30/202255,200 shares $2.91 million +1.5%N/A276 $52.80 9/15/202254,400 shares $3.10 million +56.3%N/A544 $56.96 8/31/202234,800 shares $2.20 million -8.9%N/A348 $63.29 8/15/202238,200 shares $2.42 million +17.5%N/A191 $63.29 7/31/202232,500 shares $2.44 million +0.3%N/A162.5 $75.00 7/15/202232,400 shares $2.47 million -8.7%N/A324 $76.34 6/30/202235,500 shares $2.71 million +1,083.3%N/A355 $76.34 6/15/20223,000 shares $229,020.00 -28.6%N/A30 $76.34 5/31/20224,200 shares $319,200.00 +40.0%N/A42 $76.00 5/15/20223,000 shares $231,000.00 +1,400.0%N/A30 $77.00 4/30/2022200 shares $15,400.00 -86.7%N/A2 $77.00 4/15/20221,500 shares $115,500.00 +200.0%N/A15 $77.00 3/31/2022500 shares $38,500.00 No ChangeN/A5 $77.00 3/15/2022500 shares $30,230.00 No ChangeN/A5 $60.46 2/28/2022500 shares $27,735.00 No ChangeN/A1.7 $55.47 2/15/2022500 shares $30,500.00 -28.6%N/A2.5 $61.00 1/31/2022700 shares $43,092.00 No ChangeN/A1.2 $61.56 1/15/2022700 shares $52,066.00 -93.9%N/A3.5 $74.38 12/31/202111,400 shares $712,500.00 -51.9%N/A10.4 $62.50 12/15/202123,700 shares $1.40 million +115.5%N/A79 $59.10 11/30/202111,000 shares $718,080.00 +20.9%N/A22 $65.28 11/15/20219,100 shares $650,195.00 -14.2%N/A7.6 $71.45 10/29/202110,600 shares $827,330.00 +1.0%N/A21.2 $78.05 10/15/202110,500 shares $856,800.00 +707.7%N/A52.5 $81.60 9/30/20211,300 shares $118,235.00 -86.0%N/A13 $90.95 9/15/20219,300 shares $876,246.00 -88.5%N/A46.5 $94.22 8/31/202180,900 shares $7.12 million -28.3%N/A404.5 $88.05 8/13/2021112,900 shares $9.71 million -21.7%N/A1129 $86.00 7/30/2021144,200 shares $12.33 million -17.2%N/A1442 $85.48 7/15/2021174,200 shares $15.27 million -1.3%N/A1742 $87.66Secret financial plot unfolding in Washington DC… [DEVELOPING] (Ad)What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. You see, I’ve recently uncovered a secret financial plot unfolding in Washington DC…So please take a moment to watch it now. 6/30/2021176,400 shares $16.65 million -10.2%N/A882 $94.36 6/15/2021196,500 shares $18.94 million -2.8%N/A491.3 $96.39 5/28/2021202,100 shares $19.80 million No ChangeN/A673.7 $97.96 5/14/2021202,100 shares $20.01 million +6.1%N/A673.7 $99.00 4/30/2021190,500 shares $22.67 million +1.4%N/A381 $119.00 4/15/2021187,800 shares $21.17 million +6.0%N/A626 $112.70 3/31/2021177,200 shares $19.92 million +117.2%N/A295.3 $112.40 3/15/202181,600 shares $10.18 million +6.8%N/A74.2 $124.75 2/26/202176,400 shares $10.54 million +3.1%N/A84.9 $138.00 2/12/202174,100 shares $10.60 million -27.1%N/A23.9 $143.00 1/29/2021101,700 shares $12.92 million -24.1%N/A16.4 $127.00 1/15/2021169,100 shares $16.01 million -32.8%N/A140.9 $94.70 12/31/2020149,400 shares $12.95 million -11.7%N/A747 $86.65 12/15/2020169,100 shares $15.22 million -32.8%N/A140.9 $90.00 11/30/2020251,600 shares $28.93 million +17.4%N/A359.4 $115.00 11/15/2020214,400 shares $26.03 million -6.4%N/A428.8 $121.42 10/30/2020229,100 shares $29.18 million +20.8%N/A381.8 $127.35 10/15/2020189,700 shares $29.02 million +0.2%N/A632.3 $153.00 9/30/2020189,300 shares $23.66 million +0.3%N/A1893 $125.00 9/15/2020188,800 shares $23.60 million -2.4%N/A314.7 $125.00 8/31/2020193,400 shares $19.10 million +0.8%N/A967 $98.75 8/14/2020191,800 shares $18.70 million +7.2%N/A191.8 $97.50 7/31/2020178,900 shares $18.65 million -90.6%N/A57.7 $104.25 7/15/20201,894,500 shares $20.93 million +1.5%N/A222.9 $11.05 6/30/20201,867,300 shares $16.34 million +55.7%N/A128.8 $8.75 6/15/20201,199,200 shares $9.17 million +29.1%N/A176.4 $7.65 5/29/2020928,600 shares $5.90 million +11,507.5%N/A580.4 $6.35 5/15/20208,000 shares $45,200.00 -4.8%N/A0.6 $5.65 PHMMF Short Interest - Frequently Asked Questions What is Pharma Mar's current short interest? Short interest is the volume of Pharma Mar shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 39,600 shares of PHMMF short. 0.22% of Pharma Mar's shares are currently sold short. Learn More on Pharma Mar's current short interest. What is a good short interest ratio for Pharma Mar? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PHMMF shares currently have a short interest ratio of 396.0. Learn More on Pharma Mar's short interest ratio. What is a good short interest percentage for Pharma Mar? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.22% of Pharma Mar's floating shares are currently sold short. Is Pharma Mar's short interest increasing or decreasing? Pharma Mar saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 39,600 shares, an increase of 21.1% from the previous total of 32,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pharma Mar's short interest compare to its competitors? 0.22% of Pharma Mar's shares are currently sold short. Here is how the short interest of companies in the industry of "private households" compare to Pharma Mar: Hang Lung Group Limited (0.00%), Jiangsu Expressway Company Limited (0.00%), OMRON Co. (0.03%), LEG Immobilien SE (0.03%), Indra Sistemas, S.A. (0.00%), Square Enix Holdings Co., Ltd. (0.15%), DiaSorin S.p.A. (0.37%), Spirax-Sarco Engineering plc (0.13%), Arkema S.A. (0.01%), Hikma Pharmaceuticals PLC (0.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Pharma Mar stock? Short selling PHMMF is an investing strategy that aims to generate trading profit from Pharma Mar as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pharma Mar? A short squeeze for Pharma Mar occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PHMMF, which in turn drives the price of the stock up even further. How often is Pharma Mar's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHMMF, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies HNLGY Short Interest Data JEXYY Short Interest Data OMRNY Short Interest Data LEGIF Short Interest Data ISMAY Short Interest Data SQNXF Short Interest Data DSRLF Short Interest Data SPXSF Short Interest Data ARKAY Short Interest Data HKMPF Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PHMMF) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma Mar, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharma Mar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.